Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma [1]

British Journal of Cancer

Volumn 97, Issue 4, 2007, Pages 574-575

  Roychoudhury, P ^a   Chaudhuri, K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K;

GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LETTER; MOUTH CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HUMANS; MOUTH NEOPLASMS; PILOT PROJECTS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34547916791     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603911     Document Type: Letter

References (3)

1. Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, Murray GI (2006a) The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 1765: 85-100
2. Carpenter B, McKay M, Dundas SR, Lawrie LC, Telfer C, Murray GI (2006b) Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer 95: 921-927
3. Moumen A, Masterson P, O'Connor MJ, Jackson SP (2005) hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 123: 1065-1078